Omeprazole

• Background:

  H+, K+-ATPase inhibitor (IC50 = 5.8 μM) . Clinically useful antisecretory and antiulcer agent.1 Potent inhibitor of CYP2C19 (Ki=3.1 mM) .2 Inhibits swelling-dependent chloride channels.3 Facilitates oral bioavailability of bioactive peptides such as oxytocin by raising stomach pH.4 Displays broad spectrum antiviral activity.5 Enhances efficacy of remdesivir (10-fold) .6

• Conjugation:

  Unconjugated

• Buffer:

  White solid

• Storage Conditions:

  -20°C